George A. Freeman

2.4k total citations · 1 hit paper
26 papers, 2.0k citations indexed

About

George A. Freeman is a scholar working on Infectious Diseases, Molecular Biology and Organic Chemistry. According to data from OpenAlex, George A. Freeman has authored 26 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Infectious Diseases, 10 papers in Molecular Biology and 9 papers in Organic Chemistry. Recurrent topics in George A. Freeman's work include HIV/AIDS drug development and treatment (15 papers), Biochemical and Molecular Research (9 papers) and Synthesis and Characterization of Heterocyclic Compounds (7 papers). George A. Freeman is often cited by papers focused on HIV/AIDS drug development and treatment (15 papers), Biochemical and Molecular Research (9 papers) and Synthesis and Characterization of Heterocyclic Compounds (7 papers). George A. Freeman collaborates with scholars based in United States, United Kingdom and China. George A. Freeman's co-authors include Janet L. Rideout, James A. Fyfe, M H St Clair, S Broder, P A Furman, Sandra Nusinoff Lehrman, Dani P. Bolognesi, Kent J. Weinhold, Hiroaki Mitsuya and Steven A. Short and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Medicinal Chemistry and Antimicrobial Agents and Chemotherapy.

In The Last Decade

George A. Freeman

24 papers receiving 1.9k citations

Hit Papers

Phosphorylation of 3'-azido-3'-deoxythymidine and selecti... 1986 2026 1999 2012 1986 250 500 750 1000
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Phosphorylation of 3'-azido-3'-deoxythymidine and selective interaction of the 5'-triphosphate with human immunodeficiency virus reverse transcriptase.
    1986 1.2k citations P A Furman, James A. Fyfe et al. Proceedings of the National Academy of Sciences profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
George A. Freeman United States 16 1.1k 809 645 549 409 26 2.0k
Derek Kinchington United Kingdom 17 954 0.8× 726 0.9× 589 0.9× 325 0.6× 307 0.8× 41 1.5k
Janet L. Rideout United States 16 1.2k 1.1× 747 0.9× 1.1k 1.8× 358 0.7× 726 1.8× 33 2.5k
Neil R. Hartman United States 19 1.1k 1.0× 917 1.1× 503 0.8× 163 0.3× 454 1.1× 41 1.9k
Joseph A. Martin United Kingdom 21 1.0k 0.9× 635 0.8× 784 1.2× 582 1.1× 388 0.9× 42 2.1k
J P Sommadossi United States 21 1.1k 1.0× 621 0.8× 774 1.2× 326 0.6× 666 1.6× 49 2.0k
Bo Öberg Sweden 28 1.2k 1.1× 745 0.9× 878 1.4× 373 0.7× 1.1k 2.6× 76 2.8k
Wayne H. Miller United States 26 1.2k 1.1× 740 0.9× 1.1k 1.7× 465 0.8× 1.3k 3.1× 50 2.9k
J C Quintero United States 13 1.7k 1.5× 1.6k 2.0× 529 0.8× 352 0.6× 280 0.7× 19 2.3k
Harry Ford United States 24 681 0.6× 326 0.4× 1.2k 1.8× 464 0.8× 392 1.0× 58 1.8k
Anné-Marie Aubertin France 29 873 0.8× 1.0k 1.3× 1.1k 1.7× 826 1.5× 441 1.1× 102 2.6k

Countries citing papers authored by George A. Freeman

Since Specialization
Citations

This map shows the geographic impact of George A. Freeman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by George A. Freeman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites George A. Freeman more than expected).

Fields of papers citing papers by George A. Freeman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by George A. Freeman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by George A. Freeman. The network helps show where George A. Freeman may publish in the future.

Co-authorship network of co-authors of George A. Freeman

This figure shows the co-authorship network connecting the top 25 collaborators of George A. Freeman. A scholar is included among the top collaborators of George A. Freeman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with George A. Freeman. George A. Freeman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Duan, Maosheng, George A. Freeman, Robert G. Ferris, et al.. (2011). Synthesis and evaluation of 2-phenyl-1,4-butanediamine-based CCR5 antagonists for the treatment of HIV-1. Bioorganic & Medicinal Chemistry Letters. 21(5). 1394–1398. 9 indexed citations
2.
Gudmundsson, Kristjan S., Brian A. Johns, Zhicheng Wang, et al.. (2005). Synthesis of novel substituted 2-phenylpyrazolopyridines with potent activity against herpesviruses. Bioorganic & Medicinal Chemistry. 13(18). 5346–5361. 48 indexed citations
3.
Allen, Scott H., Brian A. Johns, Kristjan S. Gudmundsson, et al.. (2005). Synthesis of C-6 substituted pyrazolo[1,5-a]pyridines with potent activity against herpesviruses. Bioorganic & Medicinal Chemistry. 14(4). 944–954. 38 indexed citations
4.
Ferris, Robert G., Richard Hazen, M H St Clair, et al.. (2005). Antiviral Activity of GW678248, a Novel Benzophenone Nonnucleoside Reverse Transcriptase Inhibitor. Antimicrobial Agents and Chemotherapy. 49(10). 4046–4051. 51 indexed citations
5.
Johns, Brian A., Kristjan S. Gudmundsson, Elizabeth M. Turner, et al.. (2005). Pyrazolopyridine antiherpetics: SAR of C2′ and C7 amine substituents. Bioorganic & Medicinal Chemistry. 13(7). 2397–2411. 50 indexed citations
6.
Romines, Karen R., George A. Freeman, Lee T. Schaller, et al.. (2005). Structure−Activity Relationship Studies of Novel Benzophenones Leading to the Discovery of a Potent, Next Generation HIV Nonnucleoside Reverse Transcriptase Inhibitor. Journal of Medicinal Chemistry. 49(2). 727–739. 144 indexed citations
7.
8.
Chan, Joseph H., George A. Freeman, Jeffrey H. Tidwell, et al.. (2004). Novel Benzophenones as Non-nucleoside Reverse Transcriptase Inhibitors of HIV-1. Journal of Medicinal Chemistry. 47(5). 1175–1182. 52 indexed citations
9.
Zou, Ruiming, Etsuko Kawashima, George A. Freeman, et al.. (2000). Design, Synthesis, and Antiviral Evaluation of 2-Deoxy-D-Ribosides of Substituted Benzimidazoles as Potential Agents for Human Cytomegalovirus Infections. Nucleosides Nucleotides & Nucleic Acids. 19(1-2). 125–153. 14 indexed citations
10.
Freeman, George A., Dean W. Selleseth, Janet L. Rideout, & Richard J. Harvey. (2000). Benzimidazole 2′-Isonucleosides: Design, Synthesis, and Antiviral Activity of 2-Substituted-5,6-Dichlorobenzimidazole 2′-Isonucleosides. Nucleosides Nucleotides & Nucleic Acids. 19(1-2). 155–174. 6 indexed citations
11.
Gudmundsson, Kristjan S., George A. Freeman, John C. Drach, & Leroy B. Townsend. (2000). ChemInform Abstract: Synthesis of Fluorosugar Analogues of 2,5,6‐Trichloro‐1‐(β‐D‐ribofuranosyl)benzimidazole as Antivirals with Potentially Increased Glycosidic Bond Stability.. ChemInform. 31(40). 1 indexed citations
12.
Townsend, Leroy B., Kristjan S. Gudmundsson, Susan M. Daluge, et al.. (1999). Studies Designed to Increase the Stability and Antiviral Activity (HCMV) of the Active Benzimidazole Nucleoside, TCRB. Nucleosides and Nucleotides. 18(4-5). 509–519. 27 indexed citations
13.
Freeman, George A., Steven A. Short, Richard J. Harvey, et al.. (1996). Synthesis and Antiviral Activity of 2‘-Deoxy-4‘-thio Purine Nucleosides. Journal of Medicinal Chemistry. 39(2). 538–542. 53 indexed citations
14.
Freeman, George A., Sammy R. Shaver, Janet L. Rideout, & Steven A. Short. (1995). 2-amino-9-(3-azido-2,3-dideoxy-β-d-erythro-pentofuranosyl)-6-substituted-9H-purines: Synthesis and anti-HIV activity. Bioorganic & Medicinal Chemistry. 3(4). 447–458. 19 indexed citations
15.
Freeman, George A., Janet L. Rideout, Wayne H. Miller, & John E. Reardon. (1992). 3'-Azido-3',5'-dideoxythymidine-5'-methylphosphonic acid diphosphate: synthesis and HIV-1 reverse transcriptase inhibition.. Journal of Medicinal Chemistry. 35(17). 3192–3196. 40 indexed citations
16.
Almond, Merrick R., et al.. (1991). Synthesis of 2-amino-9-(3′-azido-2′,3′-dideoxy-beta-D-erythro-pentofuranosyl)-6-methoxy-9H-purine (AzddMAP) and AzddGuo. Tetrahedron Letters. 32(41). 5745–5748. 11 indexed citations
17.
Hill, John A. & George A. Freeman. (1988). An improved synthesis of [5′‐3H]‐3′‐azido‐3′‐deoxythymidine, tritiated zidovudine. Journal of Labelled Compounds and Radiopharmaceuticals. 25(3). 277–280. 6 indexed citations
18.
Furman, P A, James A. Fyfe, M H St Clair, et al.. (1986). Phosphorylation of 3'-azido-3'-deoxythymidine and selective interaction of the 5'-triphosphate with human immunodeficiency virus reverse transcriptase.. Proceedings of the National Academy of Sciences. 83(21). 8333–8337. 1167 indexed citations breakdown →
19.
Krenitsky, Thomas A., et al.. (1983). 3'-Amino-2',3'-dideoxyribonucleosides of some pyrimidines: synthesis and biological activities. Journal of Medicinal Chemistry. 26(6). 891–895. 20 indexed citations
20.
Freeman, George A., et al.. (1980). A Reinvestigation of the Dichlorination of Thymidine. Synthetic Communications. 10(9). 685–688. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Derek Kinchington Breakdown of academic impact, for papers by Janet L. Rideout Breakdown of academic impact, for papers by Neil R. Hartman Breakdown of academic impact, for papers by Joseph A. Martin Breakdown of academic impact, for papers by J P Sommadossi Breakdown of academic impact, for papers by Bo Öberg Breakdown of academic impact, for papers by Wayne H. Miller Breakdown of academic impact, for papers by J C Quintero Breakdown of academic impact, for papers by Harry Ford Breakdown of academic impact, for papers by Anné-Marie Aubertin
Rankless by CCL
2026